Fermenta Biotech Ltd - 506414 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to the provisions of Regulation 24A of the Listing Regulations read with SEBI circular CIR/CFD/CMD1/27/2019 dated February 8, 2019, we are enclosing herewith the annual secretarial compliance report for the year ended March 31, 2023, issued by Pradeep Purwar & Associates, Company Secretaries. Kindly take the above on record. Fermenta Biotech Ltd - 506414 - Compliance - Related Party Transactions - March 31, 2023
In connection with our earlier intimation dated May 29, 2023 regarding the Outcome of the Board Meeting for approval of the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2023, and in accordance with Regulation 23 of Listing Regulations, we are enclosing herewith the disclosure of Related Party Transactions for the half year ended March 31, 2023. This information will also be made available at https://fermentabiotech.com/ Fermenta Biotech Ltd - 506414 - Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31, 2023 As Per Regulation 33 Of The Listing Regulations
We write to inform you that the Board of Directors of the Company at its meeting held on May 29, 2023 has, inter alia: 1. Approved the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2023 as per Regulation 33 of the Listing Regulations. The Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2023 along with the Auditors' Reports with unmodified opinion on the aforesaid Audited Financial Results (Standalone and Consolidated) issued by the Statutory Auditors, S R B C & Co. LLP, Chartered Accountants, dated May 29, 2023 are enclosed herewith. 2. Recommended final equity dividend @ Rs. 1.25/- per equity share (25%) of Rs. 5/- each for the financial year ended March 31, 2023 for members' approval. (Date of dispatch/payment of the aforesaid final equity dividend shall be announced separately once the Annual General Meeting date is decided by the Board of Directors.) Fermenta Biotech Ltd - 506414 - Board Meeting Outcome for Outcome Of Board Meeting And Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
We write to inform you that the Board of Directors of the Company at its meeting held on May 29, 2023 has, inter alia: 1. Approved the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2023 as per Regulation 33 of the Listing Regulations. The Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2023 along with the Auditors' Reports with unmodified opinion on the aforesaid Audited Financial Results (Standalone and Consolidated) issued by the Statutory Auditors, S R B C & Co. LLP, Chartered Accountants, dated May 29, 2023 are enclosed herewith. 2. Recommended final equity dividend @ Rs. 1.25/- per equity share (25%) of Rs. 5/- each for the financial year ended March 31, 2023 for members' approval. (Date of dispatch/payment of the aforesaid final equity dividend shall be announced separately once the Annual General Meeting date is decided by the Board of Directors.) Fermenta Biotech Ltd - 506414 - Execution Of Sale Deed.
Further to our earlier intimation dated June 9, 2022 in relation to the members' approval obtained to sell, lease, or otherwise dispose of the portion of Company's assets being premises located in Thane One Building, DIL Complex, Ghodbunder Road, Majiwade, Thane (West) 400 610, we wish to inform you that the Company has executed and registered a sale deed on May 25, 2023 to sell premises situated at the 1st floor in Thane One Building, DIL Complex, Ghodbunder Road, Majiwade, Thane (West) 400 610 on the terms and conditions mentioned in the sale deed and as approved by the Board of Directors of the Company. The information regarding the aforesaid sale of premises is provided in Annex-'A' herewith. This intimation is given under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 for your records. Fermenta Biotech Ltd - 506414 - Update On Composite Scheme Of Amalgamation And Arrangement - Effective Date
In continuation to our letter dated May 22, 2023, we wish to inform you that the Company has filed the certified copy of order passed by the National Company Law Tribunal, Mumbai Bench ('NCLT') approving the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('Transferor Company 1') and Aegean Properties Limited ('Transferor Company 2') and Fermenta Biotech Limited ('Transferee Company' or 'Company') and their respective Shareholders ('Order') with the Registrar of Companies, Mumbai in e-Form INC- 28 on May 24, 2023, along with the said scheme. Accordingly, the said scheme becomes effective from May 24, 2023. Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting - Regulation 30 And 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - NCLT Order And Record Date
The Board of Directors of the Company, inter alia, considered and noted the certified copy of the order passed by the National Company Law Tribunal, Mumbai Bench ('NCLT') dated May 08, 2023, issued on May 12, 2023 ('NCLT Order'), sanctioning the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('Transferor Company 1') and Aegean Properties Limited ('Transferor Company 2') and Fermenta Biotech Limited ('Transferee Company' or 'Company') and their respective Shareholders ('Scheme'). In accordance with Regulation 42(1)(e) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has fixed Friday, June 2, 2023 as the Record Date, following the effectiveness of the Scheme, for determining the shareholders of Transferor Company 1 who shall be entitled to receive shares of the Company, as consideration pursuant to the Scheme. Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Notice Of Board Meeting
Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 29, 2023, inter alia: (i) to consider and approve the audited financial results of the Company (standalone and consolidated) for the quarter and financial year ended March 31, 2023; and (ii) to consider and recommend final equity dividend, if any, for the financial year 2022-23. Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from the shareholder about loss of share certificates on May 18, 2023